Gene-editing therapy shows durable success in common cholesterol disorder, paving way for one-shot treatments
Gene-editing therapies are delivering sustained cholesterol reductions in early trials for a common lipid disorder. The approach targets liver genes that regulate LDL cholesterol, offering potential one-time treatment. These results…
